These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10840517)

  • 1. Cisapride to be taken off market, placed in controlled-access plan.
    Am J Health Syst Pharm; 2000 May; 57(9):834. PubMed ID: 10840517
    [No Abstract]   [Full Text] [Related]  

  • 2. Cisapride: limited access and alternatives.
    Richter JE
    Cleve Clin J Med; 2000 Jul; 67(7):471-2. PubMed ID: 10902234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe cardiac arrythmia on cisapride.
    Prescrire Int; 2000 Oct; 9(49):144-5. PubMed ID: 11603415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug recalls underscore safety concerns.
    Greene HL
    Health News; 2000 May; 6(5):4. PubMed ID: 10851966
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA, Janssen bolster cardiac risk warnings for cisapride.
    Miller JL
    Am J Health Syst Pharm; 2000 Mar; 57(5):414. PubMed ID: 10711516
    [No Abstract]   [Full Text] [Related]  

  • 6. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.
    Wysowski DK; Corken A; Gallo-Torres H; Talarico L; Rodriguez EM
    Am J Gastroenterol; 2001 Jun; 96(6):1698-703. PubMed ID: 11419817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisapride--a word of caution.
    Rana S; Sharma B
    J Assoc Physicians India; 2001 Apr; 49():495. PubMed ID: 11762637
    [No Abstract]   [Full Text] [Related]  

  • 8. New safety recommendations for use of cisapride (Propulsid).
    Harv Heart Lett; 2000 Apr; 10(8):7. PubMed ID: 10712753
    [No Abstract]   [Full Text] [Related]  

  • 9. Prepulsid withdrawn from UK & US markets.
    Griffin JP
    Adverse Drug React Toxicol Rev; 2000 Aug; 19(3):177. PubMed ID: 11059358
    [No Abstract]   [Full Text] [Related]  

  • 10. Postoperative ileus: a preventable event (Br J Surg 2000; 87: 1480-93).
    Cheetham M
    Br J Surg; 2001 Apr; 88(4):595. PubMed ID: 11298634
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced access to gastric motility drug will not sit well with many physicians or patients.
    Gordon D
    Gastroenterology; 2000 May; 118(5):818. PubMed ID: 10841640
    [No Abstract]   [Full Text] [Related]  

  • 12. Postoperative ileus: a preventable event (Br J Surg 2000; 87: 1480-93).
    Sunil S; Sinha S
    Br J Surg; 2001 Apr; 88(4):594-5. PubMed ID: 11298633
    [No Abstract]   [Full Text] [Related]  

  • 13. Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States.
    Enger C; Cali C; Walker AM
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):477-86. PubMed ID: 12426932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The arrhythmogenic potentials of cisapride].
    Telò D
    G Ital Cardiol; 1998 Dec; 28(12):1458. PubMed ID: 9887403
    [No Abstract]   [Full Text] [Related]  

  • 15. Cisapride: questions and answers.
    El Sayed A; Shammaa M
    J Med Liban; 2000; 48(5):338. PubMed ID: 12489590
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisapride (Prepulsid): interactions with grapefruit and drugs.
    Morawiecka I
    CMAJ; 2000 Jan; 162(1):105-6, 109-10. PubMed ID: 11216183
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future.
    Layton D; Key C; Shakir SA
    Pharmacoepidemiol Drug Saf; 2003; 12(1):31-40. PubMed ID: 12616845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in related drug class utilization after market withdrawal of cisapride.
    Glessner MR; Heller DA
    Am J Manag Care; 2002 Mar; 8(3):243-50. PubMed ID: 11915974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cisapride and risk of cardiac complications].
    Cataldo F
    Minerva Pediatr; 1999; 51(9-10):309-11. PubMed ID: 10783591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NASPGN and ESPGHAN on the use of cisapride.
    Spielberg SP
    J Pediatr Gastroenterol Nutr; 2000 Aug; 31(2):212-3. PubMed ID: 10941984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.